Effectiveness of nivolumab persists long-term in advanced renal cell carcinoma
Follow-up data from phase I and phase II clinical trials [...]
Cabozantinib extends survival in advanced kidney cancer compared to axitinib
Results from the phase III METEOR clinical trial, which compares [...]
Nivolumab extends survival for advanced renal cell carcinoma patients treated beyond disease progression
Results from the phase III CheckMate-025 study presented at the [...]
Pazopanib before surgery is safe for metastatic kidney cancer
A recent study reported in the journal JAMA Oncology and conducted [...]
New generation mTOR inhibitors for drug-resistant cancer
Resistance to cancer drugs continues to be a major impediment [...]
Exercise reduces risk of cancer
A recent review provides further evidence that exercise reduces the [...]
New robot at Norfolk and Norwich Hospital for cancer surgery
Norfolk and Norwich University Hospital has a new £1m robot [...]
Genetically engineered CD4 T cells show promise for cancer
Research being conducted at the National Cancer Institute in America [...]
First patient dosed in pivotal phase 3 clinical trial of tivozanib in renal cell carcinoma
AVEO Oncology has enrolled and dosed the first patient in [...]
